Imunon, Inc. Proceeds from Sale of Available-for-sale Securities
Imunon, Inc. (IMNN) reported Proceeds from Sale of Available-for-sale Securities of $138.00 thousand for the 3-month period ending 2012-12-31, per its 10-K filed 2015-03-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2015-03-12
- Imunon, Inc. proceeds from sale of available-for-sale securities for the quarter ending 2012-12-31 was $138.00K.
| Period end | Proceeds from Sale of Available-for-sale Securities 1 month | Proceeds from Sale of Available-for-sale Securities 3 month |
|---|---|---|
| 2012-12-31 | $138.00K 10-K · filed 2013-03-18 | $138.00K 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |